CH
STIM icon

Canton Hathaway’s Neuronetics STIM Stock Holding History

Canton Hathaway’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.4K Buy
+10,000
New +$24.6K ﹤0.01% 268

Other funds holding STIM

T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Canton Hathaway's STIM Position: Q3 2026 in Review

Canton Hathaway opened a new position in Neuronetics (STIM) in Q3 2026: 10,000 shares worth $23.4K. The stake represents ﹤0.01% of the portfolio and ranks #268 among its holdings.

7 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • Canton Hathaway held 10,000 shares of Neuronetics worth $23.4K as of Q3 2026.
  • Neuronetics was a new Canton Hathaway position in Q3 2026.
  • Neuronetics made up ﹤0.01% of Canton Hathaway's portfolio in Q3 2026, its #268 holding.
  • 7 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Canton Hathaway's 13F filing for Q3 2026, filed 23 Oct 2026.